AMAG Pharmaceuticals Inc (NASDAQ:AMAG)
| 44.19 Data as of Jan 30 |  -0.49 / -1.10%Today’s Change | 16.49 Today|||52-Week Range 48.50 | +3.68% Year-to-Date |
Latest AMAG News | Press Releases
| SurModics Beats on Q1 Earnings, Reaffirms 2015 Guidance - Analyst Blog Jan 30 / Zacks.com | Array BioPharma (ARRY) Jumps: Stock Adds 9.8% in Session - Tale of the Tape Jan 27 / Zacks.com |
| Alexion Pharmaceuticals (ALXN) Jumps: Stock Rises 5.8% - Tale of the Tape Jan 30 / Zacks.com | Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog Jan 23 / Zacks.com |
| Alexion Misses on Q4 Earnings, 2015 Outlook Disappoints - Analyst Blog Jan 29 / Zacks.com | Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog Jan 22 / Zacks.com |
| Celgene Q4 Earnings & Revenues In Line, Revlimid Sales Up - Analyst Blog Jan 29 / Zacks.com | Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog Jan 21 / Zacks.com |
| CEL-SCI Corp. (CVM) in Focus: Stock Adds 7.5% in Session - Tale of the Tape Jan 28 / Zacks.com | Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog Jan 21 / Zacks.com |
Today’s Trading
| Previous close | 44.68 |
| Today’s open | 44.53 |
| Day’s range | 43.66 - 44.93 |
| Volume | 431,352 |
| Average volume (3 months) | 512,072 |
| Market cap | $976.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 01/30/2015
Growth & Valuation
| Earnings growth (last year) | +43.59% |
| Earnings growth (this year) | +101.52% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | -5.30% |
| P/E ratio | NM |
| Price/Sales | 6.52 |
| Price/Book | 5.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GHDXGenomic Health Inc | -0.10 | -0.31% |
| QDELQuidel Corp | -0.93 | -3.80% |
| VIVOMeridian Bioscience ... | -0.48 | -2.70% |
| BDSIBioDelivery Sciences... | -0.53 | -3.89% |
Data as of 4:00pm ET, 01/30/2015
Financials
| Next reporting date | March 2, 2015 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $80.9M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -11.88% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Operating Officer & Executive Vice President Frank E. Thomas |
Corporate headquarters Lexington, Massachusetts |
Forecasts
.